| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/15/2004 | US20040137438 Encoding transporter of the inner mitochondrial membrane; able to inhibit the expression of a MCF (mitochondrial carrier family) in a host cell in antisense orientation to a promoter; use in modification of transport properties |
| 07/15/2004 | US20040137437 Human source leading sequence, gene vector and gene expression strategy |
| 07/15/2004 | US20040137436 Method for measuring drug resistance |
| 07/15/2004 | US20040137435 Human abc transporter expressed in liver,atil |
| 07/15/2004 | US20040137433 CNG3B: a novel cyclic nucleotide-gated cation channel |
| 07/15/2004 | US20040137429 Of given nucleotide sequence; Complexed with a toxin moiety; Use in treating human immunodeficiency virus (HIV) |
| 07/15/2004 | US20040137427 Retentate chromatography and protein chip arrays with applications in biology and medicine |
| 07/15/2004 | US20040137421 Deposition of the protein in the follicular dendritic cell of a non-human animal and detection by histology, electrophoresis or binding assay |
| 07/15/2004 | US20040137420 Irradiating a laser to a intracellular region and analyzing the mass ions; determining the chemical structure by correlating with molecular weight; matrix-assisted laser desorption/ionization time-of-flight mass spectrometry |
| 07/15/2004 | US20040137074 Osteoprotegerin in milk |
| 07/15/2004 | US20040137064 Compositions and processes using siRNA, amphipathic compounds and polycations |
| 07/15/2004 | US20040137017 amino acid sequence of subunit A of a cholera toxin (CT-A) or a fragment of the amino acid sequence of subunit A of an Escherichia coli heat labile toxin (LT-A) or a fragment, where in Ser-63 and Arg-192 are replaced with another amino acid |
| 07/15/2004 | US20040137015 equine influenza virus genome segment confers at least one identifying phenotype of a cold-adapted equine influenza virus on the reassortant virus, and genetically-engineered equine influenza viruses, produced through reverse genetics |
| 07/15/2004 | US20040137011 Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance |
| 07/15/2004 | US20040137010 gp120 and a nucleic acid aptamer that binds to gp120 and induces gp120 to undergo a conformational shift whereby an epitope to a membrane bound receptor is exposed that is capable of eliciting a humoral immune response |
| 07/15/2004 | US20040137009 DNA encoding a derivative of a human interferon- alpha selected from DNA encoding a protein in which one or more amino acid residues of the protein encoded by the above DNA have been replaced, deleted, and/or added |
| 07/15/2004 | US20040137007 includes polypeptides that contain at least one antigenic portion of a Chlamydia antigen and DNA sequences encoding such polypeptides |
| 07/15/2004 | US20040137005 Chlamydia protein, sequence and uses thereof |
| 07/15/2004 | US20040137002 plasmid-encoded information, even that encoding self-destruction, will be expressed upon transfer to a recipient cell |
| 07/15/2004 | US20040137001 Human antibodies against pseudomonas aeruginosa lps derived from transgenic xenomouse |
| 07/15/2004 | US20040136995 antibody, or fragment thereof, that specifically binds an ACT-4-h-1 receptor; has different binding specificity than a monoclonal antibody generated by hybridoma HBL106 |
| 07/15/2004 | US20040136984 Mammalian galanin receptors |
| 07/15/2004 | US20040136983 as anti-tumor agent or treating excessive vascular permeability; agonist for treating trauma to vascular network |
| 07/15/2004 | US20040136981 isolated polypeptide; screening of compounds useful for treatment fo pathologic states in which histamine is involved; expression vector; host cell |
| 07/15/2004 | US20040136978 relates to the surprising finding that overexpression of ABIN prevents TNF-induced lethal hepatitis in mice |
| 07/15/2004 | US20040136976 screening for agents which decrease extracellular matrix degradation; |
| 07/15/2004 | US20040136963 Simian adenovirus vectors and methods of use |
| 07/15/2004 | US20040136958 novel sequence information regarding a specific viral vector with high binding efficiency and infectivity to cells of neural origin, endothelial cells, carcinoma cells and dendritic cells |
| 07/15/2004 | DE10352801A1 Verfahren zur Herstellung von L-Aminosäuren unter Verwendung von Methanol-Assimilierenden Bakterien A method for producing L-amino acids using methanol-assimilating bacteria |
| 07/15/2004 | DE10260537A1 Peptide mit hohem Cysteingehalt Peptides with high cysteine |
| 07/15/2004 | DE10260457A1 Mutanten des Bakterienstammes Delftia acidovorans MC1 und deren Verwendung zur Produktion von hochreinen S-Enantiomeren von 2-Phenoxypropionsäure-Derivaten Mutants of the bacterial strain Delftia acidovorans MC1 and their use for the production of highly pure S-enantiomer of 2-phenoxypropionic derivatives |
| 07/15/2004 | DE10258885A1 Verfahren zur Generierung eines gentechnisch veränderten Organismus Method for generating a genetically modified organism |
| 07/15/2004 | DE10147991B4 Verfahren zur Diagnose von chronisch entzündlichen Darmerkrankungen A method of diagnosing inflammatory bowel disease |
| 07/15/2004 | CA2774928A1 Binding agents which inhibit myostatin |
| 07/15/2004 | CA2756797A1 Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection |
| 07/15/2004 | CA2518966A1 Artificial promoter for the expression of dna sequences in vegetal cells |
| 07/15/2004 | CA2511967A1 Generation of immunoglobulin molecules with predetermined specificity |
| 07/15/2004 | CA2511910A1 Dual specific single domain antibodies specific for a ligand and for the receptor of the ligand |
| 07/15/2004 | CA2511652A1 Enzymes and polynucleotides encoding the same |
| 07/15/2004 | CA2511625A1 Modified vaccinia ankara expressing p53 in cancer immunotherapy |
| 07/15/2004 | CA2511553A1 Process for producing dipeptides |
| 07/15/2004 | CA2511522A1 Novel proteins and use thereof |
| 07/15/2004 | CA2511503A1 Method and device for optimizing a nucleotide sequence for the purpose of expression of a protein |
| 07/15/2004 | CA2511475A1 Immunostimulatory sequence oligonucleotides and methods of using the same |
| 07/15/2004 | CA2511436A1 Centrosome-associated protein and applications thereof |
| 07/15/2004 | CA2511359A1 Steroid receptor modulation of gene expression |
| 07/15/2004 | CA2511213A1 Chimeric protein for the screening of agonists and antagonists of cell signalling pathways that are dependent on g-protein-coupled receptors |
| 07/15/2004 | CA2511186A1 Method for altering the content of reserve substances in plants |
| 07/15/2004 | CA2511025A1 Method for producing transgenic plants having an elevated vitamin e content by modifying the serine-acetyltransferase content |
| 07/15/2004 | CA2511013A1 Multivalent lymphotoxin beta receptor agonists and therapeutic uses thereof |
| 07/15/2004 | CA2511012A1 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof |
| 07/15/2004 | CA2510884A1 Fluorescent proteins from copepoda species and methods for using same |
| 07/15/2004 | CA2510561A1 Malate dehydrogenase as a target for herbicides |
| 07/15/2004 | CA2510362A1 Methods for evaluating genetic susceptibility and therapy for chronic inflammatory diseases |
| 07/15/2004 | CA2510173A1 Vaccine compositions and methods |
| 07/15/2004 | CA2510011A1 Recessive plant viral resistance results from mutations in translation initiation factor eif4e |
| 07/15/2004 | CA2509702A1 Mutations affecting plasmid copy number |
| 07/15/2004 | CA2509568A1 Spliced variants of lgr6 |
| 07/15/2004 | CA2508957A1 Yeast-based vaccines as immunotherapy |
| 07/15/2004 | CA2508948A1 Human chondroitinase glycoprotein (chasegp), process for preparing the same, and pharmaceutical compositions comprising thereof |
| 07/15/2004 | CA2506669A1 Borrelidin-producing polyketide synthase and its uses |
| 07/15/2004 | CA2505842A1 Translational control by small, non-translatable rnas |
| 07/15/2004 | CA2495124A1 Reversible masking of liposomal complexes for targeted delivery |
| 07/15/2004 | CA2489590A1 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 07/15/2004 | CA2485348A1 Dna vaccines against hantavirus infections |
| 07/14/2004 | EP1437595A1 Orphan GPCR gene 115 for obesity indication |
| 07/14/2004 | EP1437593A1 Method of examining (-)-strand rna virus vector having lowered ability to form grains and method of constructing the same |
| 07/14/2004 | EP1437417A1 Beta-catenin oligonucleotide michrochip and method for detecting beta-catenin mutations employing same |
| 07/14/2004 | EP1437416A1 Method and equipment to monitor nucleic acid hybridization on a dna chip using four-dimensional parameters |
| 07/14/2004 | EP1437414A2 A method for promoting biocatalyst diversity |
| 07/14/2004 | EP1437413A1 Method of expressing genetically modified protein carrying sugar chain having sialic acid added thereto in insect cells |
| 07/14/2004 | EP1437412A1 Genes participating in the synthesis of fatty acid having trans-11-,cis-13- condjugated double bond and utilization thereof |
| 07/14/2004 | EP1437411A1 Glucose dehydrogenase |
| 07/14/2004 | EP1437410A1 Novel selenocystein-containing proteins |
| 07/14/2004 | EP1437409A1 Method of imparting or controlling fertility with the use of fertility restoring gene for rice bt-male sterility cytoplasm and method of judging the existence of fertility restoring gene |
| 07/14/2004 | EP1437408A1 Novel antisense oligonucleotide derivatives against hepatitis c virus |
| 07/14/2004 | EP1437407A1 Apparatus for collecting nucleic acid and method of collecting nucleic acid |
| 07/14/2004 | EP1437405A1 Gene overexpression system |
| 07/14/2004 | EP1437404A1 Tailor-made multifunctional stem cells and utilization thereof |
| 07/14/2004 | EP1437402A1 Nucleic acid extracting device |
| 07/14/2004 | EP1437401A1 Oxidoreductase |
| 07/14/2004 | EP1437400A2 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus |
| 07/14/2004 | EP1437399A1 Yeast extract solution, its preparation and use for cell-free protein synthesis |
| 07/14/2004 | EP1437366A1 MHC antigen complexes for detecting and purifying antigen-specific T cells |
| 07/14/2004 | EP1437365A1 Use of cardiotrophin in hepatic diseases |
| 07/14/2004 | EP1437364A2 Polypeptide binding to the androgen receptor and its potential use for treating breast cancer |
| 07/14/2004 | EP1437363A1 Drug transporter and use thereof |
| 07/14/2004 | EP1437043A1 Model animal with overexpression of regucalcin |
| 07/14/2004 | EP1437042A1 Hair follicle-reconstitution system and animal carrying the same |
| 07/14/2004 | EP1436761A2 Nanomachine compositions and methods of use |
| 07/14/2004 | EP1436756A2 Polymorphic marker that can be used to assess the efficacy of interferon therapy |
| 07/14/2004 | EP1436626A2 Method for selecting hla-dp4 ligands |
| 07/14/2004 | EP1436625A2 Yeast arrays, methods of making such arrays, and methods of analyzing such arrays |
| 07/14/2004 | EP1436624A1 A method of diagnosis and treatment and agents useful for same |
| 07/14/2004 | EP1436621A1 Multi-analyte assay device with multi-spot detection zone |
| 07/14/2004 | EP1436620A2 Methods and apparatus for conducting multiple measurements on a sample |
| 07/14/2004 | EP1436611A2 Biological discovery using gene regulatory networks generated from multiple-disruption expression libraries |
| 07/14/2004 | EP1436609A2 Microfluidic extraction method |
| 07/14/2004 | EP1436430A2 Antisense modulation of fibroblast growth factor receptor 3 expression |
| 07/14/2004 | EP1436429A2 Targeted nucleic acid constructs and uses related thereto |